OFIX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Orthofix Medical Inc (OFIX) is not a strong buy at this time for a beginner investor with a long-term strategy. The stock shows weak financial performance, no significant positive catalysts, and bearish technical indicators. While analysts maintain a Buy rating with lowered price targets, the lack of immediate growth visibility and negative sentiment in options data suggest holding off on investment for now.
The stock's technical indicators are bearish. The moving averages show a downward trend (SMA_200 > SMA_20 > SMA_5). RSI is neutral at 40.754, and the MACD histogram is slightly positive at 0.0229 but not strongly expanding. Key support levels are at 11.255 and 11.038, with resistance at 11.958 and 12.175. The stock is trading near its support levels, indicating potential downside risk.
NULL identified. No recent news or significant insider/hedge fund activity. Analysts maintain Buy ratings but have lowered price targets.
Weak financial performance in Q4 2025, with a significant drop in net income (-92.38% YoY) and EPS (-92.00% YoY). Options data shows a high Put-Call Open Interest Ratio (63.47), indicating bearish sentiment. No recent congress trading data or influential figure activity to support the stock.
In Q4 2025, revenue increased by 1.97% YoY to $219.91M, but net income dropped significantly to -$2.22M (-92.38% YoY), and EPS fell to -$0.06 (-92.00% YoY). Gross margin improved slightly to 69.7% (+4.03% YoY), but overall profitability remains weak.
Analysts maintain Buy ratings but have lowered price targets recently. Stifel reduced the target to $18 (from $22), Canaccord to $20 (from $24), and Barrington to $17 (from $18). TD Cowen initiated coverage with a Hold rating and a $14 price target, citing the need for evidence of accelerating sales for the stock to perform.
